All News
Filter News
Found 808,690 articles
-
Soligenix to Present at the 2018 ESCMID/ASM Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
8/29/2018
Soligenix, Inc. announced today that Dr. Oreola Donini, Chief Scientific Officer, will be presenting preclinical and clinical data illustrating the potential utility of the Innate Defense Regulator technology in the treatment of infectious disease in a poster session at the upcoming European Society of Clinical Microbiology and Infectious Diseases / American Society of Microbiology Conference
-
Over 130 Iconic Buildings and Landmarks in Canada and the U.S. to be Illuminated in Support of Stand Up To Cancer's Sixth Live Telecast
8/29/2018
The 3D TORONTO Sign, Calgary Tower, CN Tower, Kipnes Lantern/National Arts Centre, New York Stock Exchange, Niagara Falls, and Peace Bridge Among Famous Canada and U.S. Locations to Light Up in the Colors of Stand Up To Cancer
-
iWi® Expands to Sam's Club to Launch Algae-based Omega-3s Nationwide
8/29/2018
iWi (pronounced ee-we) is a wellness brand pioneering a new approach to sustainable food cultivation to produce nutritional products like omega-3s from algae.
-
Berger Montague: $4 Million Settlement Reached in Medicare Fraud Lawsuit Against Tampa Dermatologist Practice
8/29/2018
Today the United States Attorney's Office for the Middle District of Florida announced that a settlement was reached in a qui tam whistleblower suit under the False Claims Act captioned United States of America and the State of Florida ex rel. T.A.S., M.D. v. Robert A. Norman, D.O., et al., No. 8:15-cv-1506-T-23AEP.
-
Nine in 10 People Agree on the Importance of Healthy Eyes, but Half Neglect Eye Exams
8/29/2018
Most people in the U.S. don't know that eye exams can play a key role in detecting signs of common chronic conditions
-
El Kalah Shriners Hosts Annual Charity Golf Classic
8/29/2018
El Kalah Shriners is excited to announce the 5th Annual Shriners Charity Golf Classic happening on Friday, September 7, at the Thanksgiving Point Golf Course.
-
Valens signs letter of intent with Colombian-based Eticann
8/29/2018
Valens GroWorks Corp. today announced that it has signed a letter of intent with Colombian-based licensed producer Eticann S.A.S. Zomac ("Eticann") for:
-
Concord Medical Reports Financial Results for the First Half of 2018
8/29/2018
Concord Medical Services Holdings Limited today announced its unaudited consolidated financial results for the six months ended June 30, 2018[1].
-
Ionis Pharmaceuticals to Present at Upcoming September 2018 Investor Conferences
8/29/2018
Ionis Pharmaceuticals, Inc. today announced that management will present a company overview at the following investor conferences
-
SCYNEXIS, Inc. to Participate in Upcoming September 2018 Investor Conferences
8/29/2018
SCYNEXIS, Inc. announced that the Company will participate in the following upcoming investor conferences:
-
Real Warriors Campaign: Retired Army Command Sgt. Major Seeks to Educate, Save Lives on the Home Front
8/29/2018
It's Wednesday night, and retired Army Command Sgt. Maj. Christopher Greca has two feet up, watching Tom Hank's most recent film to hit premium cable.
-
ArQule to Present at the 20th Annual Global Investment Conference on September 5, 2018
8/29/2018
ArQule, Inc. today announced that Paolo Pucci, Chief Executive Officer, and Marc Schegerin, Senior Vice President, Strategy, Communication and Finance, will present at the 20th Annual Rodman & Renshaw Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC, on September 5, 2018, at 12:05pm ET at the St. Regis New York Hotel in New York City.
-
Allergan Continues Board Refreshment Process 1
8/29/2018
Director Paul Bisaro to Retire from Allergan Board
-
KinoPharma and National Institutes for Quantum and Radiological Science and Technology Launch Collaborative Research Project for Exploring New Drug Development for Alzheimer's Disease
8/29/2018
KinoPharma, Inc., and the National Institutes for Quantum and Radiological Science and Technology are pleased to announce that they have entered a contract for collaborative research on efficacy evaluation of the compound KPO1143, developed by KinoPharma
-
cGMP Compliance Status for Promethera Biosciences’ Production Site in Durham, NC Confirmed by Health Canada
8/29/2018
Promethera Biosciences SA today announced that Health Canada has confirmed a cGMP compliance status for the company’s production facility in Durham, North Carolina.
-
Innovus Pharma to Present at H.C. Wainwright 20th Annual Global Investment Conference
8/29/2018
Innovus Pharmaceuticals, Inc. today announced that Dr. Bassam Damaj, President & Chief Executive Officer, and Ryan Selhorn, Vice President, Chief Financial Officer, will present at the 2018 H.C. Wainwright 20th Annual Global Investment Conference
-
Ningxia Sustainability Summit Held Successfully in Yinchuan, Ningxia, China
8/29/2018
Achieved Multiple Collaborative Outcomes
-
Check-Cap Announces Participation at the 20th Annual Rodman & Renshaw Global Investment Conference
8/29/2018
Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK) (NASDAQ: CHEKW) (NASDAQ: CHEKZ), a clinical stage medical diagnostics company engaged in the development of C-Scan®, an ingestible capsule-based device for preparation-free colorectal cancer screening, today announced it will be featured as a presenting company at the 20th Annual Rodman & Renshaw Global Investment Conference
-
Trovagene Announces European Commission Grants Orphan Drug Designation to Onvansertib (PCM-075) for Treatment of Acute Myeloid Leukemia in Europe
8/29/2018
Trovagene, Inc.today announced that the European Commission (EC) has endorsed the positive opinion of the Committee for Orphan Medicinal Products (COMP) and has granted Orphan Drug Designation (ODD) for Onvansertib, a first-in-class, 3rd generation, oral and highly-selective Polo-like Kinase 1 (PLK1) inhibitor, for the treatment of patients with Acute Myeloid Leukemia (AML).
-
MEI Pharma To Present at Wells Fargo Securities 2018 Healthcare Conference
8/29/2018
MEI Pharma, Inc., (Nasdaq: MEIP), a pharmaceutical company focused on leveraging its extensive development and oncology expertise to identify and advance new therapies for cancer, today announced that Daniel P. Gold, Ph.D., the Company's president and chief executive officer, will present a corporate update at the Wells Fargo Securities 2018 Healthcare Conference